UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature

European journal of cancer (1990), 2024-01, Vol.197, p.113472-113472, Article 113472

2024

Volltextzugriff (PDF)

Somatostatin and somatostatin receptors in Cushing's disease

Molecular and cellular endocrinology, 2008-05, Vol.286 (1), p.199-205

Hofland, Leo J.

2008

Volltextzugriff (PDF)

Type I interferons in pancreatic cancer and development of new therapeutic approaches

Critical reviews in oncology/hematology, 2021-03, Vol.159, p.103204-103204, Article 103204

2021

Volltextzugriff (PDF)

Somatostatin analogs in the diagnosis and treatment of cancer

Trends in Endocrinology & Metabolism, 2002-12, Vol.13 (10), p.451-457

2002

Volltextzugriff (PDF)

Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice

Life sciences (1973), 2023-12, Vol.334, p.122173-122173, Article 122173

2023

Volltextzugriff (PDF)

Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor

Molecular and cellular endocrinology, 2006-06, Vol.251 (1), p.103-111

2006

Volltextzugriff (PDF)

Neuroendocrine Tumor Markers

Frontiers in neuroendocrinology, 2001-10, Vol.22 (4), p.309-339

2001

Volltextzugriff (PDF)

The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells

Biotechnology advances, 2012, Vol.30 (1), p.169-184

2012

Volltextzugriff (PDF)

Pituitary tumours: the sst/D2 receptors as molecular targets

Molecular and cellular endocrinology, 2010-09, Vol.326 (1-2), p.89-98

2010

Volltextzugriff (PDF)

Synergistic activity of everolimus and 5‐aza‐2′‐deoxycytidine in medullary thyroid carcinoma cell lines

Molecular oncology, 2017-08, Vol.11 (8), p.1007-1022

2017

Volltextzugriff (PDF)

The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features

Lung cancer (Amsterdam, Netherlands), 2017-07, Vol.109, p.128-136

2017

Volltextzugriff (PDF)

Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives

Annales d'endocrinologie, 2015-02, Vol.76 (1), p.43-58

2015

Volltextzugriff (PDF)

Type I interferons as radiosensitisers for pancreatic cancer

European journal of cancer (1990), 2011-09, Vol.47 (13), p.1938-1945

2011

Volltextzugriff (PDF)

Somatostatin receptor distribution and function in immune system

Digestive and liver disease, 2004-02, Vol.36, p.S68-S77

2004

Volltextzugriff (PDF)

The role of cortistatin in the human immune system

Molecular and cellular endocrinology, 2008-05, Vol.286 (1), p.141-147

2008

Volltextzugriff (PDF)

[ 111In-DTPA-D-Phe 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

Life sciences (1973), 1991, Vol.49 (22), p.1583-1591

1991

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

The American journal of medicine, 1994-04, Vol.96 (4), p.305-312

1994

Volltextzugriff (PDF)

Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling

Molecular and cellular endocrinology, 2013-01, Vol.365 (1), p.17-24

2013

Volltextzugriff (PDF)

Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir

Growth hormone & IGF research, 2010-12, Vol.20 (6), p.427-431

2010

Volltextzugriff (PDF)

Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field

Molecular and cellular endocrinology, 2008-05, Vol.286 (1), p.262-277

2008

Volltextzugriff (PDF)

Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes

Biochemical pharmacology, 1995-07, Vol.50 (3), p.287-297

1995

Volltextzugriff (PDF)

Surgery-Derived Reactive Oxygen Species Produced by Polymorphonuclear Leukocytes Promote Tumor Recurrence: Studies in an In Vitro Model

The Journal of surgical research, 2007-06, Vol.140 (1), p.115-120

2007

Volltextzugriff (PDF)

Somatostatin receptors: from basic science to clinical approach: Unlabeled somatostatin analogues-1: prostate cancer

Digestive and liver disease, 2004-02, Vol.36, p.S60-S67

2004

Volltextzugriff (PDF)

The Role of Neutrophils and Oxygen Free Radicals in Post-Operative Adhesions

The Journal of surgical research, 2006-11, Vol.136 (1), p.45-52

2006

Volltextzugriff (PDF)

Somatostatin is a selective chemoattractant for primitive (CD34 +) hematopoietic progenitor cells

Experimental hematology, 2002-02, Vol.30 (2), p.116-125

2002

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(122)
Buchkapitel
(1)

Sprache

Englisch
(123)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature

Somatostatin and somatostatin receptors in Cushing's disease

Type I interferons in pancreatic cancer and development of new therapeutic approaches

Somatostatin analogs in the diagnosis and treatment of cancer

Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice

Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor

Neuroendocrine Tumor Markers

The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells

Pituitary tumours: the sst/D2 receptors as molecular targets

Synergistic activity of everolimus and 5‐aza‐2′‐deoxycytidine in medullary thyroid carcinoma cell lines

The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features

Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives

Type I interferons as radiosensitisers for pancreatic cancer

Somatostatin receptor distribution and function in immune system

The role of cortistatin in the human immune system

[ 111In-DTPA-D-Phe 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

Somatostatin receptor scintigraphy: Its value in tumor localization in patients with cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion

Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling

Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir

Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field

Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes

Surgery-Derived Reactive Oxygen Species Produced by Polymorphonuclear Leukocytes Promote Tumor Recurrence: Studies in an In Vitro Model

Somatostatin receptors: from basic science to clinical approach: Unlabeled somatostatin analogues-1: prostate cancer

The Role of Neutrophils and Oxygen Free Radicals in Post-Operative Adhesions

Somatostatin is a selective chemoattractant for primitive (CD34 +) hematopoietic progenitor cells

Aktive Filter

Suchergebnisse filtern